Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study-Reference-Cited by-同舟云学术

Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study

Published:2018-02-22 Issue:6 Volume:122 Page:612-619
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Hallas Jesper¹,Margulis Andrea V.²,Pottegård Anton¹,Kristiansen Nina S.¹,Atsma Willem J.³,Appenteng Kwame⁴,de Vogel Stefan³,Kaye James A.⁵,Perez-Gutthann Susana²,Arana Alejandro²

Affiliation:

1. University of Southern Denmark; Odense C Denmark

2. RTI Health Solutions; Barcelona Spain

3. Astellas Pharma B.V.; Leiden The Netherlands

4. Astellas Pharma Global Development, Inc.; Northbrook IL USA

5. RTI Health Solutions; Waltham MA USA

Funder

Astellas Pharma Global Development

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12965/fullpdf

Reference19 articles.

1. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society;Abrams;Urology,2003

2. The prevalence and bothersomeness of lower urinary tract symptoms in women 40-60 years of age;Møller;Acta Obstet Gynecol Scand,2000

3. Characteristics of middle-aged and elderly women with urinary incontinence;Rohr;Scand J Prim Health Care,2005

4. Global prevalence and economic burden of urgency urinary incontinence: a systematic review;Milsom;Eur Urol,2014

5. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program;Pharmacoepidemiology and Drug Safety;2024-04-29

2. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses;eBioMedicine;2023-12

3. The application of lag times in cancer pharmacoepidemiology: a narrative review;Annals of Epidemiology;2023-08

4. Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study;Lung Cancer;2023-05

5. A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder;Current Medical Research and Opinion;2021-03-08